SCHEMBL2772402

SCHEMBL2772402

O=C(O)/C=C/c1ccc(Cc2ccccc2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 3/20 0.71
HDAC8 Q9BY41 3/20 0.67
HCAR2 Q8TDS4 2/20 0.67
HDAC3 O15379 2/20 0.67
HDAC1 Q13547 2/20 0.67
HDAC2 Q92769 2/20 0.67
TNKS O95271 1/20 0.67
HDAC4 P56524 1/20 0.67
HDAC7 Q8WUI4 1/20 0.67
HDAC10 Q969S8 1/20 0.67
HDAC11 Q96DB2 1/20 0.67
TNKS2 Q9H2K2 1/20 0.67
HDAC6 Q9UBN7 1/20 0.67
HDAC9 Q9UKV0 1/20 0.67
HDAC5 Q9UQL6 1/20 0.67
FFAR1 O14842 2/20 0.58
ESR1 P03372 2/20 0.57
ESR2 Q92731 2/20 0.57
CA12 O43570 2/20 0.57
AKR1B10 O60218 2/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459101 1.00 TBXAS1 (0.71) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL8921111 0.94 TBXAS1 (0.68) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL23854259 0.89 HDAC3 (0.67) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3225302 0.89 HDAC3 (0.67) TBXAS1HDAC8HCAR2HDAC3HDAC1
Bromide SCHEMBL1432660 0.85 TBXAS1 (0.56) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL4776134 0.85 TBXAS1 (0.55) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3105298 0.85 HDAC1 (0.62) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3688787 0.85 HDAC1 (0.62) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL3105287 0.85 HDAC1 (0.62) TBXAS1HDAC8HCAR2HDAC3HDAC1
SCHEMBL28357770 0.85 KDM4E (0.63) TBXAS1HDAC8HCAR2HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110914241-B Propionic acid derivatives and methods of use thereof 阿维亚拉药品有限公司 2023-11-14 CN disclosed
US-20200325363-A1 ADHESIVE COMPOSITION INCLUDING AT LEAST TWO TYPES OF DYES, ADHESIVE SHEET, AND DISPLAY DEVICE INCLUDING SAME LMS CO., LTD. (KR) 2020-10-15 US disclosed
US-20200216721-A1 ADHESIVE SHEET HAVING EXCELLENT ULTRAVIOLET BLOCKING FUNCTION, ADHESIVE COMPOSITION, AND DISPLAY DEVICE COMPRISING SAME LMS CO., LTD. (KR) 2020-07-09 US disclosed
CN-110914241-A Propionic acid derivatives and methods of use thereof 阿维亚拉药品有限公司 2020-03-24 CN disclosed
US-20190225602-A1 Propionic Acid Derivatives and Methods of Use Thereof AVIARA PHARMACEUTICALS, INC. (US) 2019-07-25 US disclosed
US-10246451-B2 Propionic acid derivatives and methods of use thereof AVIARA PHARMACEUTICALS, INC. (US) 2019-04-02 US disclosed
US-20180312498-A1 Propionic Acid Derivatives and Methods of Use Thereof AVIARA PHARMACEUTICALS, INC. (US) 2018-11-01 US disclosed
US-20140045800-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2014-02-13 US disclosed
US-8372823-B2 Tetracyclic inhibitors of fatty acid amide hydrolase THE SCRIPPS RESEARCH INSTITUTE (US) 2013-02-12 US disclosed
EP-2152082-B1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE SCRIPPS RESEARCH INST (US) 2012-08-29 EP disclosed
US-20100249078-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPS RESEARCH INSTITUTE (US) 2010-09-30 US disclosed
EP-2152082-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE The Scripps Research Institute (US) 2010-02-17 EP disclosed
WO-2008147553-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE THE SCRIPPS RESEARCH INSTITUTE (US) 2008-12-04 WO disclosed
US-3995054-A MITICIDES ZOECON CORPORATION (US) 1976-11-30 US disclosed
US-3975429-A Cyclopropanemethyl esters of cinnamic acid and derivatives thereof ZOECON CORPORATION (US) 1976-08-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10246451-B2 Propionic acid derivatives and methods of use thereof ITGA4, ITGB3, ITGB5 TBXAS1 894/4885HDAC8 1588/4885HCAR2 77/4885
US-20190225602-A1 Propionic Acid Derivatives and Methods of Use Thereof ITGA4, ITGB3, ITGB4 TBXAS1 864/4885HDAC8 1367/4885HCAR2 77/4885
US-20100249078-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, APEH TBXAS1 265/4885HDAC8 112/4885HCAR2 34/4885
US-20140045800-A1 TETRACYCLIC INHIBITORS OF FATTY ACID AMIDE HYDROLASE FAAH, FAAH2, APEH TBXAS1 265/4885HDAC8 112/4885HCAR2 34/4885
US-20180312498-A1 Propionic Acid Derivatives and Methods of Use Thereof ITGA4, ITGB3, ITGB5 TBXAS1 894/4885HDAC8 1588/4885HCAR2 77/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.